Collaboration Inquiry
Work With Us
The science is ready. The right partnerships will determine how quickly it reaches patients. We are actively seeking pharmaceutical developers, clinical researchers, and digital health organizations to validate and deploy the sRAGE biomarker strategy and the Decision Sciences simulation platform.
Pharmaceutical & Biotech
RAGE/AGE-targeted drug development, patient stratification for clinical trials, mechanism validation, and biomarker co-development for MASH, ALD, and fibrotic disease.
Clinical Research
Collaboration on sRAGE biomarker validation studies, F2 intervention window trials, and computational model integration with clinical data pipelines.
Digital Health
Integration of the Decision Sciences simulation platform into clinical decision support tools, patient risk stratification systems, and precision medicine workflows.
What to Expect
- Response within 2 business days
- Initial 30-minute discovery call
- NDA available upon request
- Full technical briefing for qualified partners
Current Priorities
- sRAGE biomarker validation study partners
- RAGE-targeted trial patient stratification
- F2 intervention window clinical collaboration
- Computational model licensing discussions